Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach

Current Molecular Medicine

Volumn 13, Issue 5, 2013, Pages 765-776

  Gross B ^a   Sgodda, M ^a   Rasche, M ^a   Schambach, A ^a   Gohring G ^a   Schlegelberger, B ^a   Greber, B ^b   Linden, T ^c   Reinhardt, D ^a   Cantz, T ^a   Klusmann, J H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Familial platelet disorders; Induced pluripotent stem cells; Runx1; Small molecules

Indexed keywords

4 [4 (1, 3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL] BENZAMIDE; HEPATOCYTE NUCLEAR FACTOR 3BETA; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MATRIGEL; MYC PROTEIN; N (2, 3 DIHYDROXYPROPOXY) 3, 4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO) BENZAMIDE; OCTAMER TRANSCRIPTION FACTOR 4; RHO KINASE INHIBITOR; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; TROPONIN T; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE SEQUENCE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MICROARRAY ANALYSIS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE DISORDER;

ANIMALS; BENZAMIDES; BLOOD PLATELET DISORDERS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CULTURE MEDIA; DIOXOLES; DIPHENYLAMINE; DRUG COMBINATIONS; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT, NEWBORN; LAMININ; MICE; NUCLEAR REPROGRAMMING; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTORS;

EID: 84881336016     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524011313050008     Document Type: Article

References (32)

1. Park IH, Lerou PH, Zhao R, Huo HG, Daley GQ. Generation of human-induced pluripotent stem cells. Nature Protocols 2008; 3(7): 1180-1186.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-676.
3. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451(7175): 141
4. Cho HJ, Lee CS, Kwon YW, et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 2010; 116(3): 386-395.
5. Shao L, Feng W, Sun Y, et al. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 2009; 19(3): 296-306.
6. Woltjen K, Michael IP, Mohseni P, et al. piggyback transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458(7239): 766.
7. Huangfu D, Maehr R, Guo W, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26(7): 795-797.
8. Lin TX, Ambasudhan R, Yuan X, et al. A chemical platform for improved induction of human iPSCs. Nature Methods 2009; 6(11): 805-824.
9. Takahashi K, Narita M, Yokura M, Ichisaka T, Yamanaka S. Human Induced Pluripotent Stem Cells on Autologous Feeders. PLoS One 2009; 4(12): e8067.
10. Warlich E, Kuehle J, Cantz T, et al. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther 2011; 19(4): 782-789.
11. Appelmann I, Linden T, Rudat A, Mueller-Tidow C, Berdel WE, Mesters RM. Hereditary thrombocytopenia and acute myeloid leukemia: a common link due to a germline mutation in the AML1 gene. Annals of Hematology 2009; 88(10): 1037-1038.
12. Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471(7336): 63-67.
13. Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471(7336): 58-62.
14. Lister R, Pelizzola M, Kida YS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471(7336): 68-73.
15. Mayshar Y, Ben David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7(4): 521-531.
16. Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009; 106(37): 15720-15725.
17. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85(8): 348-362.
18. Jia FJ, Wilson KD, Sun N, et al. A nonviral minicircle vector for deriving human iPS cells. Nature Methods 2010; 7(3): 197-U46.
19. Kim D, Kim CH, Moon JI, et al. Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins. Cell Stem Cell 2009; 4(6): 472-476.
20. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322(5903): 949-953.
21. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322(5903): 945-949.
22. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324(5928): 797-801.
23. Zhou HY, Wu SL, Joo JY, et al. Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins. Cell Stem Cell 2009; 4(5): 381-384.
24. Zhou W, Freed CR. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009; 27(11): 2667-2674.
25. Warren L, Manos PD, Ahfeldt T, et al. Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA. Cell Stem Cell 2010; 7(5): 618-630.
26. Tiemann U, Sgodda M, Warlich E, et al. Optimal Reprogramming Factor Stoichiometry Increases Colony Numbers and Affects Molecular Characteristics of Murine Induced Pluripotent Stem Cells. Cytometry A 2011; 79(6): 426-435.
27. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009; 27(3): 543-549.
28. Voelkel C, Galla M, Maetzig T, et al. Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci USA 2010; 107(17): 7805-7810.
29. Zyuz'kov GN, Gur'yantseva LA, Simanina EV, Zhdanov VV, Dygai AM, Goldberg ED. Effect of dimethylsulfoxide on the functions of mesenchymal and hemopoietic precursors. Bull Exp Biol Med 2007; 143(4): 535-538.
30. Banito A, Rashid ST, Acosta JC, et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes & Development 2009; 23(18): 2134-2139.
31. Li H, Collado M, Villasante A, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009; 460(7259): 1136.
32. Ruiz S, Panopoulos AD, Herrerias A, et al. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol 2011; 21(1): 45-52.